Bupropion
NDRI • Brands: Wellbutrin
Last reviewed: 2025-09-23
General information
Indicated for: Bupropion hydrochloride extended-release tablets (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )
Dosing & forms
- Forms/strengths: —
- Frequency: —
- Food: —
- Typical range: 150–450 mg/day (IR/SR/XL)
Mechanism (brief)
Norepinephrine–dopamine reuptake inhibitor (NDRI).
Metabolism & Half‑life
- Metabolism: CYP2B6, active metabolites.
- Half‑life: ~21 h (parent).
Therapeutic Drug Monitoring (TDM)
Recommended: No
View labelExact
Monitoring highlights
- —
Sources
- Bupropion label — DailyMed (2025)